非毒性のコア・シェルナノ粒子による光ダイナミック・セラピーは,免疫チェックポイントブロックと連携して,抗腫瘍免疫と乳がんに対する抗転移効果を誘発する.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
PubMedで要約を見る
まとめ
この要約は機械生成です。新しいナノ粒子光学療法 (PDT) は,チェックポイント阻害剤と組み合わせて,原発腫瘍を効果的に根絶し,転移を予防します. このアプローチは免疫系を活性化し 転移した癌の治療に 有望な戦略を提示します
科学分野
- 腫瘍学
- 免疫療法
- ナノ医療
背景
- チェックポイント阻害免疫療法は有効ですが,限られた患者のサブセットに利益があります.
- 腫瘍特有の無毒の免疫療法の開発は 転移したがんの治療に不可欠です
研究 の 目的
- ピロリピド (ZnP@pyro) を加えた亜鉛-ピロホスファートナノ粒子の光ダイナミック療法 (PDT) の有効性を調査する.
- ガン治療におけるZnP@pyro PDTとPD-L1チェックポイント阻害の組み合わせを評価する.
主な方法
- ZnP@pyroナノ粒子は4T1およびTUBOマウスモデルで光学療法 (PDT) に使用されました.
- 併用療法にはPDTとPD- L1抗体の治療が含まれていた.
- 腫瘍の根絶,転移の予防,全身免疫反応を評価した.
主要な成果
- ZnP@pyro PDTは直接腫瘍細胞を殺し,腫瘍の免疫性を高めました.
- 併用治療は原発腫瘍を根絶し,肺転移を予防しました.
- 全身の抗腫瘍免疫反応を示唆するアブスコパルの効果が観察された.
結論
- ナノ粒子媒介のPDTは,先天性および適応性免疫を活性化することによって,チェックポイント阻害免疫療法を強化します.
- この組み合わせ治療は,転移性乳がんの治療に有意義な可能性を示しています.
関連する概念動画
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...